Personalized Tech to turn down pain & turn up performance

$0.00 Pledged
0 Backers
0 Days Left
Raised:
0%
Goal: $50,000.00
Minimum amount is $250 Maximum amount is $500
$
By admin
9 Campaigns | 0 Loved campaigns

Story

INVEST IN HEALABLES

Personalized Tech to turn down pain
& turn up performance

HIGHLIGHTS: Things that differentiate Healables as an exceptional tech company

 

MARKET

Healables has already licensed its tech for manufacturing and its product is available for commercial sales.
This market impacts 100M people in the US alone.1,2

PEOPLE

Expert team of medical and business professionals. Founder’s prior biotech company was acquired by biopharma giant GSK (GlaxoSmithKline) for a successful exit.medical device is currently undergoing trials on patients with knee osteoarthritis, and trials are planned for fibromyalgia and diabetic neuropathy (nerve damage).

Expert team of medical and business professionals. Founder’s prior biotech company was acquired by biopharma giant GSK (GlaxoSmithKline) for a successful exit.

TECH

  • Healables medical device is currently undergoing trials on patients with knee osteoarthritis, and trials are planned for fibromyalgia and diabetic neuropathy (nerve damage).
  • Healables technology has obtained a CE mark, making it available for licensing.
  • Healables has already licensed its tech for manufacturing and its product is available for commercial sales.
  • Healables has been granted patents and has more patents pending

OUTSTANDING RESULTS IN THE FIELD

  • Olympic Athlete Training Institute “Wingate” is piloting the product, starting with their swimmers and gymnasts.
  • Intel selected Healables to join the prestigious Intel Ignite Accelerator. Less than 5% of applicants are accepted to the program.
  • Signed NDA with BMW to explore integrating Healables technology into BMW vehicles.
  • Sheba medical center wants to do a clinical trial with Healables. Healables has been accepted by the head professor of fibromyalgia at Sheba medical center, one of the top 10 hospitals in the entire world3, to do a clinical test.

12 Reasons To Invest in Healables Now

Investing in Healables is a smart choice

Our Team
Healables’ Vision
Healables’ Solution
Lead Product & Product Pipeline
Exciting Initial Data
Patented Technology
Market Size & Investment Opportunity
Timing
Validation & Partnerships
Current Product
Business Model
Milestones

Our Team

Our leadership team is comprised of experts and multi-talented professionals across a wide range of fields

ditional information you provided:

Name Position Description
Moshe Lebowitz

CEO, Co-Founder

Moshe Lebowitz is a visionary who believes that humanity is on a positive trajectory and that we all have a responsibility to solve today’s biggest health challenges. He has previously served as UI/UX Designer, Product Manager, and CEO. Lebowitz uses his rabbinic training to solve business problems differently and innovates through the creative integration of technology together with new inventions. Lebowitz practices Hasidic meditation and is trained in craniosacral therapy and Chinese medicine.
Dr. George Lowell

Chief Scientific Officer

Dr. George H. Lowell serves on the Board of Directors of BiondVax. He was Chief Scientific Officer for BioDefense at GSK Biologicals. He retired from the US Army as a Colonel where he initiated numerous clinical studies and clinical trials for FDA Approval. His academic posts include Visiting Scientist at Weizmann and Visiting Professor, Hebrew University-Hadassah Medical Center. Dr. Lowell is an early angel investor in Healables and serves on the BoD.
Yehuda Barbasch COO/CFO Yehuda Barbasch has a background in international investment banking and has worked at Citibank and Pictet Wealth Management. His exceptional people skills, British accent, and experience with all aspects of finance add up to keen business planning and operational success. Yehuda holds a BBA in International Business from Leeds Beckett University and Aix-Marseille University and speaks English, French, and Hebrew.
Ziv Ritchie BSEE – CTO Ziv Ritchie trained in Electrical Engineering at the Jerusalem College of Technology. He studied Reality Therapy at the William Glasser Institute and helped Professor Joshua Ritchie, MD found and manage the Refuah Institute, the leading provider of Torah-based coach training in the world. Ziv combines his technological knowledge and development skills with his psychological training to develop the Healables digital health coaching app and oversee the development and production of Healables electroceutical devices and textiles.
Dr. Andrew Shiller, MD Chief Medical Officer Dr. Andrew David Shiller, MD is the Chief Medical Officer. Dr. Shiller earned his MD at Duke University’s School of Medicine, continuing at Harvard Medical School, with double residency training in Internal Medicine & Physical Medicine & Rehab. He completed fellowship training in Integrative Medicine at the University of Maryland Center for Complementary Medicine Research. He studied & practiced natural healing and stress-reduction, along with nutrition, hands-on healing, movement therapy & mind/body awareness.
Marco Van Der Putten Landau CBDO Marco van der Putten Landau is an international business development and marketing professional with the rare talent, ability, and business acumen to add value and close deals by bringing people and businesses from all over the world together. Marco has lived in Europe, South America, China, and Israel and is fluent in English, Spanish, French, Portuguese, Dutch, Italian, and Chinese. Marco’s ability to understand and bridge cultural nuances empowers him to bring out the universal truths in the people that he works with and create business synergies and partnerships throughout the globe.
Yasha Harari CMO Yasha Harari is a marketing professional, having worked with a vast range of world-class products and services. He has led marketing and driven record results for a variety of top B2B, B2C, and B2B2C firms in the areas of medical devices, tech, gaming, FinTech, retail brands,

Moshe Lebowitz | CEO, Co-Founder
Moshe Lebowitz is a visionary who believes that humanity is on a positive trajectory and that we all have a responsibility to solve today’s biggest health challenges. He has previously served as UI/UX Designer, Product Manager and CEO. Lebowitz uses his rabbinic training to solve business problems differently and innovates through the creative integration of technology together with new inventions. Lebowitz practices Hasidic meditation and is trained in craniosacral therapy and Chinese medicine.

Dr. George Lowell | Chief Scientific Officer
Dr. George H. Lowell serves on the Board of Directors of BiondVax. He was Chief Scientific Officer for BioDefense at GSK Biologicals.  He retired from the US Army as a Colonel where he initiated numerous clinical studies and clinical trials for FDA Approval.  His academic posts include Visiting Scientist at Weizmann and Visiting Professor, Hebrew University-Hadassah Medical Center.  Dr. Lowell is an early angel investor in Healables and serves on the BoD.

Yehuda Barbasch | COO/CFO
Yehuda Barbasch has a background in international investment banking and has worked at Citibank and Pictet Wealth Management. His exceptional people skills, British accent and experience with all aspects of finance adds up to keen business planning and operational success. Yehuda holds a BBA in International Business from Leeds Beckett University and Aix-Marseille University and speaks English, French and Hebrew.

Ziv Ritchie | BSEE – CTO

Ziv Ritchie trained in Electrical Engineering at the Jerusalem College of Technology.  He studied Reality Therapy at the William Glasser Institute and helped Professor Joshua Ritchie, MD found and manage the Refuah Institute, the leading provider of Torah-based coach training in the world. Ziv combines his technological knowledge and development skills with his psychological training to develop the Healables digital health coaching app and oversee the development and production of Healables electroceutical devices and textiles.

Dr. Andrew Shiller, MD | Chief Medical Officer
Dr. Andrew David Shiller, MD Chief Medical Officer. Dr. Shiller earned his MD at Duke University’s School of Medicine, continuing at Harvard Medical School, with double residency training in Internal Medicine & Physical Medicine & Rehab. He completed fellowship training in Integrative Medicine at University of Maryland Center for Complementary Medicine Research. He studied & practiced natural healing and stress-reduction, along with nutrition, hands-on healing, movement therapy & mind/body awareness.

Marco Van Der Putten Landau | CBDO

Marco van der Putten Landau is an international business development and marketing professional with the rare talent, ability and business acumen to add value and close deals by bringing people and businesses from all over the world together.  Marco has lived in Europe, South America, China and Israel and is fluent in English, Spanish, French, Portuguese, Dutch, Italian and Chinese.  Marco’s ability to understand and bridge cultural nuances empowers him to bring out the universal truths in the people that he works with and create business synergies and partnerships throughout the globe.

Yasha Harari | CMO

Yasha Harari is a marketing professional, having worked with a vast range of world class products and services. He has led marketing and driven record results for a variety of top B2B, B2C and B2B2C firms in the areas of medical devices, tech, gaming, FinTech, retail brands, trade associations, consumer goods, publishers, advertising companies, and many more, around the world. Yasha is responsible for pioneering significant Internet marketing gold standards used by people worldwide since decades.

2. Healables’ vision is to heal people with smart clothing instead of drugs.

Your dollars are not just going toward a good financial investment. Your investment goes towards helping improve the quality of life of mankind. It’s like an ESG investment.

Healables microcurrent technology uses an AI-driven Health Coach to improve pain perception issues, while capturing and sharing data with therapists for optimal results.
Healables’ technology reconnects the body and the brain with improved nerves. Chronic pains. Pain is an output as an adaptation of what the body has to go through. Our treatment is mobile, making it convenient, easy to use and effective.
Early investors get to see and benefit from the progression of Healables on course to make people happier; both those suffering from various musculoskeletal conditions and/or inflammatory conditions, as well as those around them who are also impacted by what their loved ones are experiencing.
CrowdFunding investors in Healables make an impact not only on the massive amount of people suffering chronic pains and conditions. They also make an impact on those whose conditions are temporary and may be more quickly restored to a healthier and happier state.
The Problem

Worldwide, chronic pain impacts over 770 million people4. In the US, the CDC reports that approximately 20% of adults suffer from various forms of chronic pain5. That’s an astonishing 60 million people!6

Current pain management options are often limited to:

Pain medication
Meditation and breath techniques
Not much else

Pain medication can have downsides such as addiction or other physical side-effects, which leaves a gap in treatment options.

The Center for Disease Control (CDC) recommends maximizing use of non-opioid therapies6a
The 2022 CDC Clinical Practice Guideline6b, which is intended for clinicians prescribing opioids for adult outpatients with pain.

Given new findings from systematic reviews that non-opioid therapies are at least as effective as opioids for many common types of acute pain (including headaches, low back pain, neck pain, and pain related to common musculoskeletal conditions, minor surgeries, dental procedures, or kidney stones), the guideline includes a new recommendation that clinicians maximize the use of non-opioid therapies.

Clinicians should maximize use of non-opioid therapies and consider initiating opioid therapy only if the expected benefits for pain and function are anticipated to outweigh the risks and that when opioids are needed, clinicians should initiate therapy at the lowest effective dosage, carefully evaluate individual benefits and risks when considering increasing dosages, and avoid increasing the dosage above levels likely to yield diminishing returns in benefits relative to risks.

The US Congress expands access to non-opioids

The NOPAIN Act6c was passed in an end-of-year legislative package in the 117th Congress in 2022. As a result of the law, patients and providers will have expanded access to non-opioids starting in 2025.

The Non-Opioids Prevent Addiction in the Nation Act (“NOPAIN Act”) is a policy that will prevent opioid addiction before it starts by increasing the use of non-opioid pain management approaches in outpatient surgical settings.

The NOPAIN Act will increase the use of non-opioid pain management approaches by changing outdated federal reimbursement policies. The policy will:

Expand patient and provider access to FDA approved non-opioid pain management approaches in all outpatient surgical settings.
Require a report to Congress on limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for therapeutic services.

This NOPAIN Act will ensure that safe, non-addictive therapies are widely available to the tens of millions6d of Americans who undergo an outpatient surgical procedure every year. Drug-related overdoses and deaths skyrocketed6e during the COVID-19 pandemic resulting in the highest rates ever recorded. This policy change aims to reduce unnecessary exposure to opioids and the likelihood of opioid abuse or addiction following an acute pain incident.

3. Healables’ Solution

“Wearables that Heal”

Healables has developed novel wearables that dock with smart textiles and connect with AI to personalize protocols so that every user can get exactly what they need.

“More than 175 published studies show the beneficial effects of microcurrent technology — the exact kind of microcurrent medtech that Healables is bringing to market,”  Dr. Andrew David Shiller, a Harvard-trained pain rehabilitation specialist and Healables Chief Medical Officer shares.

“Throughout my medical career, I have treated over 20,000 patients with various kinds of pain and diseases of the brain, nerves, bones, joints, and muscles. The speed with which microcurrent reduces inflammation of joints, bursa, and tendons is remarkable.  I have seen chronic intractable joint pain and bone bruising resolve with very few treatments.”

Our platform enhances cell function rather than masking the pain. Microcurrent therapy involves the use of low-level electrical currents to stimulate mitochondria in the body, which can increase ATP production, promote protein synthesis, and enhance cell membrane permeability. These effects can lead to improved cellular function and tissue repair.

The Healables solution is a holistic personalized integrated medicine treatment that is made up of personalized behavioral health coaching and personalized electro therapy.

Healables is the next generation of electrotherapy because we have found a way to make it personalized and easy to use.

4. LEAD PRODUCT & PRODUCT PIPELINE:
SPORTS/WELLNESS (CE) – ELECTROGEAR PRODUCT LINE

We provide physiotherapists and personal trainers with microcurrent devices, smart compression conductive garments (body sleeves, socks & shirts) and an app with an AI health coach to improve the function, the recovery & the performance of their sports & fitness clients. Note: Our wellness device does not require FDA certification prior to sale or distribution.

NEXT PRODUCTS IN THE PIPELINE: MEDICAL – HEALABLES PRODUCT LINE

‍In Years 1-2: Treat arm, leg & back muscles, tendons, and joints to ameliorate chronic pain, accelerate healing, reduce inflammation, increase function and diminish NSAID/opioid pain med dependencies.

‍Note: Our 1st medical device will get an FDA exemption or have a 510k for typical sports- and musculoskeletal-related injuries and bruises.

‍Successful clinical trials and FDA approvals will allow us to enter the hospital and health insurance systems, thereby opening up the $2T global medical market for chronic pain & illness e.g., diabetic neuropathy and osteoarthritis.

5. Exciting Initial Data

88% of users showed 50% or greater pain relief that was often accompanied by the improved functional activity of the tissues affected.7

Healables Relieves Musculoskeletal Pains.

This graph details cases wherein our device was used to treat a variety of disorders:

Musculoskeletal complaints involving the elbow, forearm, wrist, hand, knee, shoulder, or upper or lower back

Healables Reduces Inflammatory Pains.

This graph details cases wherein our device was used to treat a variety of disorders:

Systemic complaints involving Fibromyalgia, Diabetic Neuropathy, Migraine, Respiratory, COPD

And that’s a good reason to invest in. Healables.

6. Patented Technology
What is the technology?

What are the tech breakthroughs we needed to invent in order to implement the solution?

We needed to invent the tech of dry electrodes, non contact electrodes, smart market textiles with stretchable electronics, miniaturized electronics, washability, biocompatibility, and the platform is designed to be future proofed and super charged with Artificial Intelligence.

We believe that this is the most advanced wearable therapeutic technology on the market today and it will only be more powerful when we combine the real world data sets from users with AI.

Why is the tech a good reason to invest?

Our patented tech can disrupt a broad range of verticals in multiple sectors, (ie: cosmetics, food tech, medical, veterinary, sports and wellness / fitness7b, and automotive), and that is why it is a good reason to invest in Healables’ Patented Deep Technology.

Healables’ technology delivers digital health via an App that runs an easy-to-use microcurrent technology (electron stream device) and a digital health coach to transmit microcurrent protocols via wearable e-textile garments.

Our platform enhances cell function rather than masking the pain. Microcurrent therapy involves the use of low-level electrical currents to stimulate cells in the body, which can increase ATP production, promote protein synthesis, and enhance cell membrane permeability. These effects can lead to improved cellular function and tissue repair.

Our wearable device, docked with unique conductive compression sleeves, socks, or shirts, delivers personalized treatment that empowers physiotherapists and personal trainers to provide both in-clinic as well as home-based self-treatment that health professionals can remotely monitor in a digital portal. Healable has the potential to revolutionize pain relief.

7. Market Size & Investment Opportunity

We’re building the future of pain relief: Our cutting-edge wearable microcurrent technology will revolutionize the $6.91 Billion pain relief medtech market8,8a.

‍Long-Range Market Opportunities: Total Addressable Market (TAM): $6.4T

$4.3T wellness market incl. sports injuries; supplanting NSAID/opioid pain med dependence9
100M USA persons with chronic pain & Illness: $80B market; $600B wellness device market
$2T global medical market for chronic pain & illness, e.g., diabetic neuropathy, osteoarthritis

Near-Term Primary Market Focus: Serviceable Addressable Market (SAM): $100.5B

Physiotherapy Equipment Market: Global: $19B; USA $6.5B
$75B combined US market of Physiotherapists, Chiropractors, and Personal Trainers will be the focus of B2B sales for a wellness product for these professionals to offer their clients

The Big Opportunity: Serviceable Obtainable Market (SOM) & Earlyvangelists (EVG)

Without promising any specific returns, because there is such an excellent market size in such a large market, Healables would not even need to capture 1% of the multi-trillion dollar market in order to be a billion dollar unicorn. Which means realistically, investors could see a return on investment, conservatively, at a high rate. So for example, a 40x RoI would see $250 turn into $10,000.
Competition

While there are several companies that may be considered competitors of Healables in some form, none of them on the market today delivers Healables’ combination of microcurrent, e-textiles, wearables, digital health coaching, AI and digital health telecommunications at an attractive price.

These competitors include:

H-Wave, whose products range from $1,875 to $6,300, has no Health Coach feature, has no app, has no AI, does not offer any data capture, is non-wearable and has no remote treatment capability.

Avazzia, which offers its products ranging in price form $330 to $4,780, has no Health Coach feature, has no app, has no AI, has no data capture, is not wearable, and has no remote treatment capability.

Quell, which is priced between $99 and $250, has no Health Coach feature, though it does have an app, has no AI, although it does capture data for AI, is partly wearable, yet has no remote treatment capability.

Alpha Stim, which costs $1,200, has no Health Coach feature, no app, no. AI, no data capture, is not wearable and has no remote treatment capability.

Compex, whose products cost anywhere from $800 to $1,500, has no Health Coach feature, no app, no AI, no data capture, is non-wearable, and has no remote treatment capability.

By comparison, Healables products cost $800 + SaaS fee, has a Health Coach feature, has an app, has AI (to be released in Q2 ’23), Captures data for AI, includes fully wearable, scientifically advanced, precision engineered textile, and has remote treatment capabilities.

8. Timing
The conditions are right now for electrotherapy.
1. The US Congress recently legislated the NOPAIN Act, which is a bill designed to prevent opioid addiction by increasing the use of non-opioid pain management approaches in outpatient surgical settings10,11. The NOPAIN Act is designed to increase the use of non-opioid pain management approaches by changing outdated federal reimbursement policies to make it easier for these solutions to enter the healthcare market and get to the people who need them most.12
2. The awareness of the opioid crisis has made it such that people want non pharmaceutical solutions.
By getting in on the ground floor, Healables’ CrowdFunding investors can be a part of getting in on a movement of restoring humanity to a healthier state.
Healable has done an open label trial and has succeeded in demonstrating safety and usability, and because we are before the randomized controlled trial, this is your opportunity to get in and have the most upside.
9. Validation & Partnerships

Healables has teamed up with Israel’s premiere olympic organization, The Wingate National Institute for Excellence in Sports.

Because we have established a way to validate this with an Olympic trial, this is the opportunity of a lifetime to get in before trials and bigger partnerships happen.

We are working with sports medicine expert and a baseball pitcher Dr. Michael April, who is applying Healables treatments to competitive baseball players.

In collaboration with Dr. Michael April, Chief Medical Officer at WelMetrix, together with the Head of Strategic Planning and Innovation at the Elite Sports Department at Wingate, olympic gymnasts and swimmers will be further pilot-testing ElectroGear wearable devices.

We have been invited to treat athletes at the Flag Football World Championships.

10. Current Product

We introduced our sports product called ElectroGear at CES ‘22. We are launching it in Q2 of 2023.

As a wellness product, ElectroGear already has the CE mark, which is a mark of compliance with EU health, safety, and environmental standards. ElectroGear is dedicated towards enhancing sports performance and accelerating recovery in professional and amateur athletes.

Our flagship medical product is moving through the regulatory process to demonstrate that we can reduce inflammation, relieve pain and accelerate healing without medication.

As part of the Healables solution, wearable sensors will measure physiological signals that correlate with recovery, and improvement in mobility, agility, plus speed, powering and serving as the Key Performance Indicators (KPIs) that further validate ElectroGear as a premiere performance product.

Our smart textiles are comfortable. They can be worn at home or on the go without hanging wires. They include knee sleeves, arm sleeves, smart socks, caps, shoulder textiles, and smart shirts.

In our Sports & Wellness ElectroGear™ Product Line, we offer the first ready-to-use digital health remote treatment platform. It can be used within and outside the clinic or studio of the physical therapists and personal trainers improving function, recovery & performance of their sports and fitness clients.

Coupled with a digital health coach to transmit microcurrent protocols via wearable textile garments, this unique approach in the form of digital health protocols via an AI driven App runs a proprietary easy-to-use small electron stream device that docks with any of our smart textiles.

11. Business Model

Healables’ initial product line, ElectroGear sports performance and athletic recovery products, provides an early revenue stream.

 

At present, Healables utilizes a hybrid B2B device/SaaS business model focusing on B2B practitioners such as physical therapists, physios, personal trainers, athletic trainers, massage therapists and other body workers.

Healables will be generating revenue in two different ways:

Sales of product
Licensing

Currently, the ElectroGear device is available for pre-sale. Check out www.electrogear.com to learn more.

“Healables is also in discussions with a number of major corporations about licensing our technology for integration with their current products,” explains Lebowitz.  “As the discussions are ongoing, we can’t reveal who they are until the deals are public.  Sign up for our newsletter to be the first to know about updates when they happen.”

The sports performance and wellness market has enormous potential on its own12b, yet it is dwarfed by the size of the MedTech opportunity.

‍‍The total addressable market in the MedTech space is projected to grow to $579 Billion by 2023.13

In the MedTech category, Healables’ intended applications include treatments for:

Knee arthritis
Peripheral neuropathy
Inflammation
Pain management and pain relief
Fibromyalgia
Musculoskeletal injuries

Healables platform technology is incredibly versatile. It can be deployed across multiple verticals along a number of product lines.

Initially, we’re addressing the wellness vertical through sports performance and we’re already selling in multiple countries.

In parallel, we’re working on fast-tracking the medical product line through the regulatory and reimbursement routes in the US, UK, and EU and are particularly interested in the DiGA legislation in Germany and Europe that reimburses digital health products that consumers can take home.

In addition to sports and medical verticals, our core technology can also be integrated into the cosmetic, veterinary and automotive verticals in the future.

When it comes to chronic pain, in Europe alone, the chronic pain management device market is estimated to be worth $1.45B by 2026. Additionally, the global sport/wellness market is upwards of $8B. The global medical market surpasses $2T, and the global electro-cosmetic/beauty market $50B.

12. Achieved & Upcoming Milestones
Soft-Launch, User Testing, Sports Pilot, Beta Testing, Clinical Trial
Clinical Trial: Current: Knee Osteoarthritis for safety & usability
Established Healables Digital Health as the US entity and Global Headquarters for Domestic and International commercialization of technology developed in the Israeli Healables R&D Innovation Labs. (June ’22)
Raised $1.2 Million to date
Introduced the ElectroGear Product Line for Worldwide Sports & Wellness of our pre-order campaign at Consumer Electronics Show (CES) in Vegas, Jan ’23
Sports pilot: Wingate National Institute for Sports Excellence (Israel): Olympic Swimmers: Q4 ‘22
Successful Beta testing with US-based Spectrum Ergonomics & Occupational Health Services (Pennsylvania): 92% pain relief, Q1 ’23
Approved by Professor Amital at Top 10 Worldwide Sheba Medical Center for clinical trials on fribromyalgia
Presentation to the World Physiotherapy Conference in Dubai, June ’23
Invited to Introduce Healables technology to people visiting the Healables care tent at the Flag Football World Championship which hosts 1,200 teams and 12,000 athletes, Tampa, Florida, January ’24
Updates

Updated information will be posted in this section

References
1 = Chronic Pain Market Outlook (2023 – 2033), Future Marketing Insights, https://www.futuremarketinsights.com/reports/chronic-pain-market
2,4 = Prescient & Strategic Intelligence, Chronic Pain Treatment Market Research Report https://www.psmarketresearch.com/market-analysis/chronic-pain-treatment-market
3 = World’s Best Hospitals 2021, Newsweek, https://www.newsweek.com/best-hospitals-2021/israel
5 = The Global Burden Of Chronic Pain, Tracy P. Jackson, M.D.; Victoria Sutton Stabile, B.A.; K.A. Kelly McQueen, M.D., M.P.H. ASA Newsletter June 2014, Vol. 78, 24–27. https://pubs.asahq.org/monitor/article-abstract/78/6/24/3059/The-Global-Burden-Of-Chronic-Pain?redirectedFrom=fulltext
6 = 31 Chronic Pain Statistics: US & Global Prevalence, LAURA SMITH, Associate Editorial Manager, https://www.thegoodbody.com/chronic-pain-statistics/
6a = Prescribing Opioids for Pain — The New CDC Clinical Practice Guideline, Deborah Dowell, M.D., M.P.H., Kathleen R. Ragan, M.S.P.H., Christopher M. Jones, Pharm.D., Dr.P.H., Grant T. Baldwin, Ph.D., M.P.H., and Roger Chou, M.D., New England Journal of Medicine (NEJM), https://www.nejm.org/doi/full/10.1056/NEJMp2211040
6b = CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022, Deborah Dowell, M.D., M.P.H., Kathleen R. Ragan, M.S.P.H., Christopher M. Jones, Pharm.D., Dr.P.H., Grant T. Baldwin, Ph.D., M.P.H., and Roger Chou, M.D., National Institutes of Health (NIH), National Library of Medicine, National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639433/
6c = NOPAIN Act, Voices For Non Opioid Choices, https://nonopioidchoices.org/nopain-act/
6d = New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults, National Institutes of Health (NIH), National Library of Medicine, National Center for Biotechnology Information, https://pubmed.ncbi.nlm.nih.gov/28403427/
6e = Overdose Deaths Accelerating During COVID-19, Center for Disease Control and Prevention, https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
7 = Healables compendium, Dr. Shiller, Dr. Ehrenberg, Dr. Lowell, Healables internal data
7b = The Six Reasons The Fitness Industry Is Booming, Forbes, https://www.forbes.com/sites/benmidgley/2018/09/26/the-six-reasons-the-fitness-industry-is-booming/?sh=7625abaa506d
8 = Pain Management Devices Market, Grand View Research, https://www.grandviewresearch.com/industry-analysis/pain-management-devices-market
8a – Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Cancer), By Region (APAC, North America), And Segment Forecasts, 2022 – 2030, https://www.grandviewresearch.com/press-release/global-connected-health-wellness-devices-market
9 = Statista, Wellness and Spa, https://www.statista.com/topics/1336/wellness-and-spa/#topicOverview
10= S.586 – NOPAIN Act, Sponsor: Sen. Capito, Shelley Moore [R-WV] (Introduced 03/04/2021), https://www.congress.gov/bill/117th-congress/senate-bill/586/text
11 = H.R.3259 – NOPAIN Act, Sponsor: Rep. Sewell, Terri A. [D-AL-7] (Introduced 05/14/2021), https://www.congress.gov/bill/117th-congress/house-bill/3259/text?format=txt
12 = IN CASE YOU MISSED IT:CAPITO’S NO PAIN ACT TO ADDRESS OPIOID CRISIS SIGNED INTO LAW, U.S. Senator Shelley Moore Capito (R-W.Va.), https://www.capito.senate.gov/news/press-releases/in-case-you-missed-itcapitos-no-pain-act-to-address-opioid-crisis-signed-into-law
12b = Sports Medicine Market Size to Reach USD 10270 Million by 2027 at a CAGR of 7.5% | Valuates Reports PR Newswire, https://www.prnewswire.com/news-releases/sports-medicine-market-size-to-reach-usd-10270-million-by-2027-at-a-cagr-of-7-5–valuates-reports-301388619.html
13 = Statista, Medical Technology, https://www.statista.com/outlook/hmo/medical-technology/worldwide#

Rewards

$250.00
SAPPHIRE (50 sold already)
May, 2022
Estimated Delivery
0 backers
38 rewards left
  • 20-07-2020

    This project is now live on Krowd!

    • Clinical Trial: Current: Knee Osteoarthritis for safety & usability
  • 25-09-2020

    First stretch goal announced!

    Lorem Ipsum has been the industrys standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
    • Established Healables Digital Health as the US entity and Global Headquarters for Domestic and International commercialization of technology developed in the Israeli Healables R&D Innovation Labs. (June ’22)
  • 02-01-2021

    Help us decide the next stretch goal!

    • Raised $1.2 Million to date
  • Help us decide the next stretch goal!

    Introduced the ElectroGear Product Line for Worldwide Sports & Wellness of our pre-order campaign at Consumer Electronics Show (CES) in Vegas, Jan ’23

Reviews

There are no reviews yet.

Be the first to review “Personalized Tech to turn down pain & turn up performance”

Your email address will not be published. Required fields are marked *